204 related articles for article (PubMed ID: 29633348)
1. Protozoal coinfection in horses with equine protozoal myeloencephalitis in the eastern United States.
Schale S; Howe D; Yeargan M; Morrow JK; Graves A; Johnson AL
J Vet Intern Med; 2018 May; 32(3):1210-1214. PubMed ID: 29633348
[TBL] [Abstract][Full Text] [Related]
2. Evidence of intrathecally-derived antibodies against Toxoplasma gondii in horses suspected of neurological disease consistent with equine protozoal myeloencephalitis.
Bernardino PN; Pusterla N; Conrad PA; Packham AE; Tamez-Trevino E; Aleman M; James K; Smith WA
Vet Parasitol; 2023 Jun; 318():109919. PubMed ID: 37043865
[TBL] [Abstract][Full Text] [Related]
3. Toxoplasma gondii seroprevalence and association with equine protozoal myeloencephalitis: A case-control study of Californian horses.
James KE; Smith WA; Packham AE; Conrad PA; Pusterla N
Vet J; 2017 Jun; 224():38-43. PubMed ID: 28697873
[TBL] [Abstract][Full Text] [Related]
4. Effects of blood contamination of cerebrospinal fluid on results of indirect fluorescent antibody tests for detection of antibodies against Sarcocystis neurona and Neospora hughesi.
Finno CJ; Packham AE; David Wilson W; Gardner IA; Conrad PA; Pusterla N
J Vet Diagn Invest; 2007 May; 19(3):286-9. PubMed ID: 17459859
[TBL] [Abstract][Full Text] [Related]
5. Equine protozoal myeloencephalitis.
Howe DK; MacKay RJ; Reed SM
Vet Clin North Am Equine Pract; 2014 Dec; 30(3):659-75. PubMed ID: 25441115
[TBL] [Abstract][Full Text] [Related]
6. Accurate antemortem diagnosis of equine protozoal myeloencephalitis (EPM) based on detecting intrathecal antibodies against Sarcocystis neurona using the SnSAG2 and SnSAG4/3 ELISAs.
Reed SM; Howe DK; Morrow JK; Graves A; Yeargan MR; Johnson AL; MacKay RJ; Furr M; Saville WJ; Williams NM
J Vet Intern Med; 2013; 27(5):1193-200. PubMed ID: 24033423
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of antibodies to Sarcocystis neurona and Neospora hughesi in horses from Mexico.
Yeargan MR; Alvarado-Esquivel C; Dubey JP; Howe DK
Parasite; 2013; 20():29. PubMed ID: 24016396
[TBL] [Abstract][Full Text] [Related]
8. Comparison of prevalence factors in horses with and without seropositivity to Neospora hughesi and/or Sarcocystis neurona.
Pusterla N; Tamez-Trevino E; White A; Vangeem J; Packham A; Conrad PA; Kass P
Vet J; 2014 May; 200(2):332-4. PubMed ID: 24703324
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of Neospora, Toxoplasma gondii and Sarcocystis neurona antibodies in horses from Jeju island, South Korea.
Gupta GD; Lakritz J; Kim JH; Kim DY; Kim JK; Marsh AE
Vet Parasitol; 2002 Jun; 106(3):193-201. PubMed ID: 12062508
[TBL] [Abstract][Full Text] [Related]
10. Pathological, immunohistochemical, and molecular findings of equine protozoal myeloencephalitis due to Sarcocystis neurona infection in Brazilian horses.
Henker LC; Bandinelli MB; de Andrade CP; Bianchi MV; Sonne L; Driemeier D; Soares JF; Pavarini SP
Trop Anim Health Prod; 2020 Nov; 52(6):3809-3817. PubMed ID: 33011934
[TBL] [Abstract][Full Text] [Related]
11. Therapeutics for Equine Protozoal Myeloencephalitis.
Pusterla N; Tobin T
Vet Clin North Am Equine Pract; 2017 Apr; 33(1):87-97. PubMed ID: 28161037
[TBL] [Abstract][Full Text] [Related]
12. Reactivity against Sarcocystis neurona and Neospora by serum antibodies in healthy French horses from two farms with previous equine protozoal myeloencephalitis-like cases.
Pitel PH; Lindsay DS; Caure S; Romand S; Pronost S; Gargala G; Mitchell SM; Hary C; Thulliez P; Fortier G; Ballet JJ
Vet Parasitol; 2003 Jan; 111(1):1-7. PubMed ID: 12523974
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalences of anti-Sarcocystis neurona and anti-Neospora hughesi antibodies among healthy equids in the United States.
James KE; Smith WA; Conrad PA; Packham AE; Guerrero L; Ng M; Pusterla N
J Am Vet Med Assoc; 2017 Jun; 250(11):1291-1301. PubMed ID: 28509641
[TBL] [Abstract][Full Text] [Related]
14. Equine Protozoal Myeloencephalitis: An Updated Consensus Statement with a Focus on Parasite Biology, Diagnosis, Treatment, and Prevention.
Reed SM; Furr M; Howe DK; Johnson AL; MacKay RJ; Morrow JK; Pusterla N; Witonsky S
J Vet Intern Med; 2016; 30(2):491-502. PubMed ID: 26857902
[TBL] [Abstract][Full Text] [Related]
15. Serologic prevalence of Sarcocystis neurona, Toxoplasma gondii, and Neospora caninum in horses in Brazil.
Dubey JP; Kerber CE; Granstrom DE
J Am Vet Med Assoc; 1999 Oct; 215(7):970-2. PubMed ID: 10511862
[TBL] [Abstract][Full Text] [Related]
16. Risk of transplacental transmission of Sarcocystis neurona and Neospora hughesi in California horses.
Duarte PC; Conrad PA; Barr BC; Wilson WD; Ferraro GL; Packham AE; Carpenter TE; Gardner IA
J Parasitol; 2004 Dec; 90(6):1345-51. PubMed ID: 15715226
[TBL] [Abstract][Full Text] [Related]
17. Antibody coefficients for the diagnosis of equine protozoal myeloencephalitis.
Furr M; Howe D; Reed S; Yeargan M
J Vet Intern Med; 2011; 25(1):138-42. PubMed ID: 21155894
[TBL] [Abstract][Full Text] [Related]
18. Neosporosis as a cause of equine protozoal myeloencephalitis.
Marsh AE; Barr BC; Madigan J; Lakritz J; Nordhausen R; Conrad PA
J Am Vet Med Assoc; 1996 Dec; 209(11):1907-13. PubMed ID: 8944807
[TBL] [Abstract][Full Text] [Related]
19. Equine Protozoal Myeloencephalitis.
MacKay RJ; Howe DK
Vet Clin North Am Equine Pract; 2022 Aug; 38(2):249-268. PubMed ID: 35810151
[TBL] [Abstract][Full Text] [Related]
20. Utility of C-reactive protein and serum amyloid A in the diagnosis of equine protozoal myeloencephalitis.
Mittelman NS; Stefanovski D; Johnson AL
J Vet Intern Med; 2018 Sep; 32(5):1726-1730. PubMed ID: 30216559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
